A population-based study of 1102 Canadian children found infants with bone and soft tissue tumors had poorer survival, driven ...

After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates ...

Liver disease disparities tied to insurance and race spanned HCC surveillance, transplant listing, and drug access in data at ...

SMART-MASH found about a third more patients with cirrhosis than Agile 4 while using costly fibrosis tests in only some ...

Started at advanced fibrosis or cirrhosis, pegozafermin lowered liver collagen below baseline and prevented liver cancer in a ...

ETNK1 fusion in MDS/MPN with eosinophilia; the fusion disappeared when disease relapsed as AML after transplant.

Hepatitis B functional cure with bepirovirsen held in 90% to 92% of responders 48 weeks after stopping all therapy, per data at The Liver Meeting 2026.

GOLD leaders say COPD is diagnosed too late and its smoking-only image is outdated, and the 2027 report puts rehab and ...

Harvard Medical School’s Emily S. Wan, MD, discusses mucus plugs in COPD, how to detect them, and what would make them a treatment target.

Most patients with CLL/SLL who discontinued a first-line BTK inhibitor did not start second-line therapy, and older age was ...

The University of Exeter’s David Halpin, MA, DPhil, discusses inhaler device selection, single vs multiple inhalers, and the pharmacist’s role in COPD.

Resmetirom real-world data at The Liver Meeting 2026 show 12-month gains in liver stiffness, fat, and enzymes among patients ...